Neuland Laboratories Ltd.

₹12152.0

Neuland Laboratories Ltd.

₹12152.0

₹12152.0

-126.0 (-1.03%) - 30 Apr 2025 12:26 PM

About Company

Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The company provides solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life-cycle, as well as commercial launch. Its core competency lies in the application of strong process chemistry to manufacturing in a regulatory compliant environment. Neuland has been at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs.

Market Cap. ₹15,753 Cr.
52 Week - High/Low ₹18,100/5,540
P/E Ratio 52.92
P/B Ratio 12.34
Enterprise Value ₹15,758 Cr.
ROE % 26.48
RSI Value 50.85
EMA 50 12280.07
EMA 200 11913.59
Market Cap. ₹15,753 Cr.
52 Week - High/Low ₹18,100/5,540
P/E Ratio 52.82
P/B Ratio 12.28
Enterprise Value ₹15,758 Cr.
ROE % 26.38
RSI Value 50.85
EMA 50 12280.07
EMA 200 11913.59

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.